Related Experiment Video
Updated: May 16, 2026
07:39
How to Obtain Reliable Visual Event-related Potentials in Newborns
Published on: October 24, 2019
Parents' knowledge and perceptions regarding vitamin K prophylaxis in newborns
Smadar Eventov-Friedman1, Orit Vinograd, Maggie Ben-Haim
1Department of Neonatology, Hebrew University School of Nursing, Faculty of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. smadaref@hadassah.org.il
Journal of Pediatric Hematology/Oncology
|December 18, 2012
Summary
Expecting parents often lack knowledge about vitamin K (VK) prophylaxis for newborns, citing various barriers. Increased education on VK
Area of Science:
- Neonatal care
- Pediatric health
- Public health
Background:
- Increasing parental refusal of vitamin K (VK) prophylaxis in newborns.
- Need to understand parental knowledge, perceptions, and barriers to VK prophylaxis.
Purpose of the Study:
- To examine expecting parents' knowledge, perceptions, and cultural/religious barriers regarding newborn VK prophylaxis.
Main Methods:
- Survey administered to 217 expecting parents (151 female, 85% first-time parents).
- Assessed knowledge on VK recommendation, source, action, and provision options.
Main Results:
- Despite academic backgrounds, participants showed significant ignorance about VK prophylaxis details.
- First-time parents were less likely to decide on VK administration post-birth (P<0.05).
Conclusions:
- Essential to educate expecting parents on the safety, utility, and benefits of VK prophylaxis.
- Addressing parental concerns and misinformation is crucial for improving VK uptake.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:30Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...